Novartis AG (NVS)
NVS trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$142.41
-0.99% on the day
Market cap
$271.7B
Mega cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | NVS on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Switzerland |
| IPO year | Not reported by the screener |
| SEC CIK | 0001114448 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | V8 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-17 |
| Latest annual report | 20-F | 2026-02-04 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-09-08 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.5% |
| 1 month | +6.0% |
| 3 months | -3.8% |
| Year to date | +6.5% |
| 1 year | +13.8% |
| From 52-week high | -12.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AZN | AstraZeneca PLC | $155.82 | -1.58% | $241.6B |
| MRK | Merck & Company Inc. Common Stock (new) | $141.98 | -2.39% | $350.3B |
| ABT | Abbott Laboratories | $102.61 | +0.78% | $177.6B |
| NVO | Novo Nordisk A/S | $38.06 | -1.35% | $168.5B |
| PFE | Pfizer Inc. | $28.37 | -0.11% | $161.7B |
| ABBV | AbbVie Inc. | $274.36 | -2.40% | $484.8B |
| JNJ | Johnson & Johnson | $248.61 | -5.73% | $599.1B |
| VRTX | Vertex Pharmaceuticals Incorporated | $485.22 | -4.30% | $123.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier